How to Sell a Urology Practice
Learn how to sell a urology practice: how ancillaries and PE platforms drive value, buyer types, preparation, and running a confidential, competitive sale.
In this article
- Why urology attracts strong buyer interest
- What drives the value of a urology practice
- Who buys urology practices?
- How to prepare your urology practice for sale
- How Tenet M&A helps you sell a urology practice
- Urology practices for sale: ancillary revenue and the platform buyers
- Frequently asked questions about selling a urology practice
Urology practices sell for a multiple of Adjusted EBITDA, with ancillaries — pathology, imaging, radiation oncology, and in-office procedures — driving much of the value. PE-backed urology platforms and hospitals compete for scaled groups with real provider depth. See typical ranges in our valuation multiples by specialty guide.
Urology has consolidated rapidly, first through large single-specialty groups and more recently through private-equity-backed platforms. Rich ancillary revenue, an aging patient population, and a shift of procedures to the outpatient setting have made urology practices highly attractive to buyers. For owners, that demand can support a strong exit — if you understand what today’s buyers value and run a disciplined process. This page explains how to sell a urology practice and how Tenet M&A helps you maximize value.
Tenet M&A advises urologists on confidential sales, partnerships, and transitions. When you are ready, we help you sell your urology practice the right way. For the full process, see our complete guide to selling a practice.
Why urology attracts strong buyer interest
Urology pairs recurring chronic-condition care with high-value procedures and an unusually deep ancillary menu. In-office dispensing, pathology, imaging, radiation for prostate cancer, and surgery-center ownership can each add a profit pool beyond professional fees. Large urology groups pioneered this integrated model, and PE-backed platforms have followed — giving well-run practices multiple competing buyers.
What drives the value of a urology practice
- Ancillary ownership. In-office dispensing, pathology, imaging, and radiation add high-margin revenue that lifts value.
- Surgery-center interest. An ASC stake captures facility revenue as procedures move outpatient.
- Procedural and case mix. Strong surgical and in-office procedure volume signals durable earnings.
- Provider depth. Multiple urologists and advanced-practice providers reduce owner dependence.
- Demographics and referrals. An aging population and broad referral base increase strategic appeal.
See our medical practice valuation guide and what drives higher or lower valuations.
Wondering how this applies to your practice? A Tenet advisor can walk you through it in a confidential call.
Talk to an advisorWho buys urology practices?
Urology sellers typically attract PE-backed urology platforms, large single-specialty groups, health systems, and individual physicians. Platform buyers often pay premium multiples for practices with strong ancillaries, frequently offering equity rollover and physician-led governance. Weigh the trade-offs in selling to private buyers vs. MSOs or platforms.
How to prepare your urology practice for sale
Prepare 12 to 36 months ahead. Document ancillary and ASC economics, strengthen provider depth, keep clean financials with a clear add-back schedule, secure referral relationships, and resolve compliance and coding issues before diligence. These steps directly raise the multiple — see how to prepare your practice for sale.
How Tenet M&A helps you sell a urology practice
Tenet M&A runs a confidential, competitive process built for urology — a healthcare-specific valuation that captures ancillary and ASC value, careful preparation, access to platform and strategic buyers, and skilled negotiation of price and terms. Explore our advisory services or start a confidential conversation. This page is educational and not tax or legal advice.
Urology practices for sale: ancillary revenue and the platform buyers
A urology practice valuation depends heavily on what you have built around the clinical practice — in-office procedures, pathology, imaging, radiation oncology interests and infusion. These are what lift a practice from being valued on physician earnings to a multiple of Adjusted EBITDA, and they explain why advertised figures for a urology practice for sale vary so widely.
Urology platforms have been assembling regional groups for several years and approach owners directly. A urology practice broker or M&A advisor who brings several of those platforms to the table at once changes the dynamic, because a single approach gives you nothing to measure the offer against.
See how your specialty compares in our valuation multiples by specialty guide, explore how we represent sellers, or start a confidential conversation.
Frequently asked questions about selling a urology practice
How much is my urology practice worth?
Urology practices are valued on a multiple of Adjusted EBITDA, with ancillary ownership (dispensing, pathology, imaging, radiation), surgery-center interest, procedural volume, and provider depth driving the multiple. Ancillary-rich practices can command premium values.
Why is private equity buying urology practices?
Urology offers recurring chronic care, high-value procedures, and a deep ancillary menu — complementary, high-margin revenue streams that scale well in a roll-up, supported by favorable demographics.
Do ancillaries increase my practice’s value?
Typically yes. In-office dispensing, pathology, imaging, radiation, and a surgery-center interest add high-margin revenue that platform buyers value highly, often materially raising a urology practice’s worth.
How long does it take to sell a urology practice?
Most sales take about eight to sixteen months from preparation to closing. Starting early lets you optimize ancillaries and run a competitive process.
What is a urology practice worth?
It depends largely on ancillary revenue. In-office procedures, pathology, imaging, radiation oncology interests and infusion services can move a urology practice from being valued on physician earnings to a multiple of Adjusted EBITDA, which is typically the higher outcome.
Planning a sale or transition?
Talk through timing, structure and likely buyers in a confidential conversation with a Tenet advisor.

